Syndax Pharmaceuticals, Inc. announced a private placement of 1,421,523 shares at a price of $24.62 per share for gross proceeds of $35 million on September 24, 2021. The transaction will include participation from Incyte Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.8 USD | +3.16% | +4.02% | +10.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.13% | 2.02B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |
- Stock
- Equities
- Stock Syndax Pharmaceuticals, Inc. - Nasdaq
- News Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals, Inc. announced that it expects to receive $34.997896 million in funding from Incyte Corporation